Bank of New York Mellon’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $369K | Sell |
2,332
-1,460
| -39% | -$197K | ﹤0.01% | 3893 |
|
|
2026
Q1 | $484K | Buy |
3,792
+18
| +0.5% | +$2.25K | ﹤0.01% | 3624 |
|
|
2025
Q4 | $460K | Sell |
3,774
-455
| -11% | -$52.2K | ﹤0.01% | 3655 |
|
|
2025
Q3 | $424K | Sell |
4,229
-450
| -10% | -$40.5K | ﹤0.01% | 3685 |
|
|
2025
Q2 | $388K | Buy |
4,679
+599
| +15% | +$47.8K | ﹤0.01% | 3653 |
|
|
2025
Q1 | $331K | Sell |
4,080
-359
| -8% | -$32.1K | ﹤0.01% | 3661 |
|
|
2024
Q4 | $400K | Sell |
4,439
-1,176
| -21% | -$114K | ﹤0.01% | 3635 |
|
|
2024
Q3 | $555K | Buy |
5,615
+25
| +0.4% | +$2.46K | ﹤0.01% | 3457 |
|
|
2024
Q2 | $518K | Buy |
5,590
+744
| +15% | +$66.7K | ﹤0.01% | 3568 |
|
|
2024
Q1 | $460K | Sell |
4,846
-55
| -1% | -$5.1K | ﹤0.01% | 3573 |
|
|
2023
Q4 | $438K | Sell |
4,901
-277
| -5% | -$20.6K | ﹤0.01% | 3626 |
|
|
2023
Q3 | $378K | Sell |
5,178
-447
| -8% | -$35.7K | ﹤0.01% | 3691 |
|
|
2023
Q2 | $468K | Sell |
5,625
-11,269
| -67% | -$942K | ﹤0.01% | 3637 |
|
|
2023
Q1 | $1.29M | Buy |
16,894
+100
| +0.6% | +$8.3K | ﹤0.01% | 3029 |
|
|
2022
Q4 | $1.39M | Buy |
16,794
+11,099
| +195% | +$899K | ﹤0.01% | 3035 |
|
|
2022
Q3 | $452K | Buy |
5,695
+1,181
| +26% | +$99.6K | ﹤0.01% | 3615 |
|
|
2022
Q2 | $336K | Sell |
4,514
-93
| -2% | -$6.98K | ﹤0.01% | 3823 |
|
|
2022
Q1 | $414K | Sell |
4,607
-2,632
| -36% | -$243K | ﹤0.01% | 3824 |
|
|
2021
Q4 | $811K | Sell |
7,239
-4,189
| -37% | -$505K | ﹤0.01% | 3505 |
|
|
2021
Q3 | $1.44M | Buy |
11,428
+747
| +7% | +$96.2K | ﹤0.01% | 3195 |
|
|
2021
Q2 | $1.45M | Sell |
10,681
-40
| -0.4% | -$5.26K | ﹤0.01% | 3203 |
|
|
2021
Q1 | $1.45M | Buy |
10,721
+1,047
| +11% | +$157K | ﹤0.01% | 3109 |
|
|
2020
Q4 | $1.36M | Buy |
9,674
+853
| +10% | +$109K | ﹤0.01% | 3066 |
|
|
2020
Q3 | $983K | Buy |
8,821
+7
| +0.1% | +$785 | ﹤0.01% | 3135 |
|
|
2020
Q2 | $987K | Sell |
8,814
-445
| -5% | -$43.8K | ﹤0.01% | 3126 |
|
|
2020
Q1 | $717K | Sell |
9,259
-4,595
| -33% | -$407K | ﹤0.01% | 3194 |
|
|
2019
Q4 | $1.32M | Sell |
13,854
-1,926
| -12% | -$167K | ﹤0.01% | 3090 |
|
|
2019
Q3 | $1.2M | Sell |
15,780
-1,554
| -9% | -$129K | ﹤0.01% | 3065 |
|
|
2019
Q2 | $1.52M | Sell |
17,334
-650
| -4% | -$55.4K | ﹤0.01% | 2965 |
|
|
2019
Q1 | $1.63M | Sell |
17,984
-525
| -3% | -$44.7K | ﹤0.01% | 2894 |
|
|
2018
Q4 | $1.33M | Sell |
18,509
-3,345
| -15% | -$270K | ﹤0.01% | 2943 |
|
|
2018
Q3 | $2.1M | Buy |
21,854
+1,435
| +7% | +$139K | ﹤0.01% | 2816 |
|
|
2018
Q2 | $1.94M | Sell |
20,419
-4,483
| -18% | -$412K | ﹤0.01% | 2860 |
|
|
2018
Q1 | $2.18M | Buy |
24,902
+3,688
| +17% | +$337K | ﹤0.01% | 2761 |
|
|
2017
Q4 | $1.8M | Buy |
21,214
+2,282
| +12% | +$191K | ﹤0.01% | 2901 |
|
|
2017
Q3 | $1.64M | Sell |
18,932
-342
| -2% | -$27.4K | ﹤0.01% | 2946 |
|
|
2017
Q2 | $1.49M | Buy |
19,274
+197
| +1% | +$14K | ﹤0.01% | 3017 |
|
|
2017
Q1 | $1.32M | Sell |
19,077
-2,659
| -12% | -$179K | ﹤0.01% | 3090 |
|
|
2016
Q4 | $1.29M | Buy |
21,736
+4,009
| +23% | +$247K | ﹤0.01% | 3120 |
|
|
2016
Q3 | $1.18M | Buy |
17,727
+2,521
| +17% | +$156K | ﹤0.01% | 3084 |
|
|
2016
Q2 | $822K | Buy |
15,206
+1,078
| +8% | +$59.1K | ﹤0.01% | 3267 |
|
|
2016
Q1 | $730K | Sell |
14,128
-1,438
| -9% | -$74.7K | ﹤0.01% | 3243 |
|
|
2015
Q4 | $1.09M | Buy |
15,566
+2,201
| +16% | +$150K | ﹤0.01% | 3118 |
|
|
2015
Q3 | $832K | Buy |
13,365
+417
| +3% | +$32.9K | ﹤0.01% | 3299 |
|
|
2015
Q2 | $1.09M | Sell |
12,948
-855
| -6% | -$66.5K | ﹤0.01% | 3295 |
|
|
2015
Q1 | $1.04M | Sell |
13,803
-522
| -4% | -$36.5K | ﹤0.01% | 3288 |
|
|
2014
Q4 | $890K | Buy |
14,325
+867
| +6% | +$49.4K | ﹤0.01% | 3364 |
|
|
2014
Q3 | $700K | Buy |
13,458
+3
| +0% | +$153 | ﹤0.01% | 3494 |
|
|
2014
Q2 | $691K | Sell |
13,455
-6
| -0% | -$271 | ﹤0.01% | 3507 |
|
|
2014
Q1 | $639K | Buy |
13,461
+2,526
| +23% | +$129K | ﹤0.01% | 3491 |
|
|
2013
Q4 | $475K | Buy |
10,935
+735
| +7% | +$30.4K | ﹤0.01% | 3596 |
|
|
2013
Q3 | $439K | Sell |
10,200
-2,142
| -17% | -$86.8K | ﹤0.01% | 3564 |
|
|
2013
Q2 | $428K | Buy |
+12,342
| New | +$434K | ﹤0.01% | 3554 |
|
Other funds holding XBI
MIH
Bank of New York Mellon's XBI Position: Q2 2026 in Review
Bank of New York Mellon reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 39% in Q2 2026, selling an estimated $197K and leaving 2,332 shares worth $369K. The position accounts for ﹤0.01% of the portfolio, ranked #3893.
Bank of New York Mellon first reported a position in XBI in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.18M in Q1 2018. 746 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Bank of New York Mellon held 2,332 shares of State Street SPDR S&P Biotech ETF worth $369K as of Q2 2026.
- Bank of New York Mellon sold 1,460 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $197K.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3893 holding.
- Bank of New York Mellon first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 53 quarters since.
- Bank of New York Mellon's State Street SPDR S&P Biotech ETF position peaked at $2.18M in Q1 2018.
- 746 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.